AKT1 and medulloblastoma: Here, we show that Axitinib in combination with GDC‐0941 displays enhanced cytotoxic and anti‐proliferative efficacy alongside with a complete abrogation of AKT and STAT3 signalling in c‐myc‐amplified medulloblastoma.